Skip to main content
Clinical Trials/JPRN-UMIN000052641
JPRN-UMIN000052641
Not yet recruiting
未知

Establishment of a method for predicting therapeutic efficacy and adverse effects of drug therapy for hepatocellular carcinoma using tests related to the intestinal microbiota and elucidation of the mechanism - Establishment of a method for predicting therapeutic efficacy and adverse effects of drug therapy for hepatocellular carcinoma using tests related to the intestinal microbiota and elucidation of the mechanism

agoya University0 sites100 target enrollmentDecember 7, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Hepatitis, Hepatocellular Carcinoma, Liver cirrhosis
Sponsor
agoya University
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 7, 2023
End Date
March 31, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
agoya University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients with galactosemia Patients who have experienced allergies to foods containing sugar alcohols Patients with poorly controlled diabetes Patients who wish to be excluded from the study Patients who are pregnant, nursing, possibly pregnant or wish to become pregnant, or wishing to raise children Other patients whom the physician has judged to be inappropriate for safely conducting this trial

Outcomes

Primary Outcomes

Not specified

Similar Trials